March 2014 QPS360 Newsletter Seventh Edition
QPS Receives CRO Leadership Awards, Winning in All Five Categories
Rapid Turnaround PK/PD Screening Programs for your CNS Drug Candidates
Powerful Amyloid Staining Options at QPS
New Drug Assays added to the QPS Global Assay Database
Translational Medicine
FDA Helping to Usher in a New Era of Personalized Medicine
New Biomarker Assays at QPS Are Paving the Way for Personalized Medicine
Early Stage Clinical
Paul A. Lehman, QPS Vice President and Head of Dermal and Transdermal Research
Co- authors Book Chapter on Establishing the Bioequivalence (BE) of Topical Drug
Phase II - IV Clinical
QPS Respiratory & Allergy News
Howard Schwartz, Medical Director of QPS Miami Research Associates Co-Authors Daclatasvir-Sofosbuvir Combination HCV Trial Published in The New England Journal Of Medicine